Insider Trading & Ownership - CinCor Pharma Inc. (CINC)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for CinCor Pharma Inc.
Goto 0, 1, Next
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-11-28
Sale
2023-02-27
9:15 pm
CinCor Pharma Inc.CINCHEALY JAMES
Katabi Maha
Sofinnova Management X L.P.
Sofinnova Management X-A L.L.C.
Sofinnova Venture Partners X L.P.
Director
10% Owner
6,000$14.32$85,9200
(Indirect
Direct)
View
2022-06-10
Sale
2023-02-27
5:10 pm
CinCor Pharma Inc.CINCFreeman Mason
Chief Medical Officer
6$15.21$910
(Indirect
Direct)
View
2022-08-15
Purchase
2022-08-17
8:01 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
10% Owner
600,000$30$18,000,000983,656
(Indirect)
View
2022-08-15
Purchase
2022-08-17
4:19 pm
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
133,333$30$3,999,9904,220,979
(Indirect)
View
2022-08-11
Purchase
2022-08-15
3:46 pm
CinCor Pharma Inc.CINCSofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
Katabi Maha
10% Owner
500,000$30$15,000,0006,073,949
(Indirect)
View
2022-08-11
Purchase
2022-08-15
3:45 pm
CinCor Pharma Inc.CINCHEALY JAMES
Director
10% Owner
506,000$30$15,180,00035,411
(Indirect
Direct)
View
2022-08-11
Purchase
2022-08-15
2:22 pm
CinCor Pharma Inc.CINCGENERAL ATLANTIC GENPAR (BERMUDA) L.P.
GAP (Bermuda) L.P.
GAP Coinvestments CDA L.P.
General Atlantic (CIN) L.P.
General Atlantic (SPV) GP LLC
10% Owner
83,000$30$2,490,0004,209,470
(Indirect)
View
2022-08-11
Purchase
2022-08-15
2:21 pm
CinCor Pharma Inc.CINCGENERAL ATLANTIC L.P.
GENERAL ATLANTIC GENPAR L.P.
General Atlantic Partners 100 L.P.
GAP COINVESTMENTS III LLC
GAP COINVESTMENTS IV LLC
GAP Coinvestments V LLC
General Atlantic Partners (Bermuda) EU L.P.
General Atlantic Partners (Lux) SCSp
General Atlantic (Lux) S.a r.l.
General Atlantic GenPar (Lux) SCSp
10% Owner
83,000$30$2,490,0004,209,470
(Indirect)
View
2022-01-11
Purchase
2022-01-13
9:32 pm
CinCor Pharma Inc.CINCGENERAL ATLANTIC GENPAR (BERMUDA) L.P.
GAP (Bermuda) L.P.
GAP Coinvestments CDA L.P.
General Atlantic (CIN) L.P.
General Atlantic (SPV) GP LLC
10% Owner
1,700,000$16$27,200,0004,126,470
(Indirect)
View
2022-01-11
Purchase
2022-01-13
9:32 pm
CinCor Pharma Inc.CINCGENERAL ATLANTIC L.P.
GENERAL ATLANTIC GENPAR L.P.
General Atlantic Partners 100 L.P.
GAP COINVESTMENTS III LLC
GAP COINVESTMENTS IV LLC
GAP Coinvestments V LLC
General Atlantic Partners (Bermuda) EU L.P.
General Atlantic Partners (Lux) SCSp
General Atlantic (Lux) S.a r.l.
General Atlantic GenPar (Lux) SCSp
10% Owner
1,700,000$16$27,200,0004,126,470
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:45 pm
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
470,000$16$7,520,000496,323
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:38 pm
CinCor Pharma Inc.CINCSofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
Katabi Maha
10% Owner
325,000$16$5,200,0005,573,949
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:36 pm
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
220,000$16$3,520,0004,087,646
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:33 pm
CinCor Pharma Inc.CINCHEALY JAMES
Director
10% Owner
325,000$16$5,200,0005,573,949
(Indirect)
View
2022-01-11
Purchase
2022-01-13
4:31 pm
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
2,250$16$36,000132,411
(Indirect
Direct)
View
2022-01-11
Purchase
2022-01-13
4:28 pm
CinCor Pharma Inc.CINCFreeman Mason
EVP Clinical Development
2,600$16$41,6002,600
(Indirect
Direct)
View
2022-01-11
Purchase
2022-01-13
4:26 pm
CinCor Pharma Inc.CINCde Garidel Marc
Chief Executive Officer
12,500$16$200,00012,500
(Direct)
View
2022-01-11
Purchase
2022-01-13
4:24 pm
CinCor Pharma Inc.CINCCoelho Mary Theresa
EVP CFO & Chief BD Officer
100$16$1,600100
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-02-24
Equity Swap
2023-02-28
4:29 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
5AM Opportunities II (GP) LLC
5AM Opportunities II L.P.
5AM Opportunities I (GP) LLC
10% Owner
4,937,646$00
(Indirect)
View
2023-02-24
Disposition
2023-02-27
9:15 pm
N/A
N/A
CinCor Pharma Inc.CINCHEALY JAMES
Katabi Maha
Sofinnova Management X L.P.
Sofinnova Management X-A L.L.C.
Sofinnova Venture Partners X L.P.
Director
10% Owner
19,608$00
(Direct)
View
2023-02-24
Equity Swap
2023-02-27
9:15 pm
N/A
N/A
CinCor Pharma Inc.CINCHEALY JAMES
Katabi Maha
Sofinnova Management X L.P.
Sofinnova Management X-A L.L.C.
Sofinnova Venture Partners X L.P.
Director
10% Owner
6,083,752$00
(Direct)
View
2023-02-24
Disposition
2023-02-27
5:10 pm
N/A
2029-09-24
CinCor Pharma Inc.CINCFreeman Mason
Chief Medical Officer
335,854$00
(Direct)
View
2023-02-24
Equity Swap
2023-02-27
5:10 pm
N/A
N/A
CinCor Pharma Inc.CINCFreeman Mason
Chief Medical Officer
2,594$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:40 pm
N/A
2031-12-09
CinCor Pharma Inc.CINCAllison David D.
Director
33,353$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:40 pm
N/A
2031-06-17
CinCor Pharma Inc.CINCIgnelzi Troy A.
Director
95,147$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:38 pm
N/A
2032-11-03
CinCor Pharma Inc.CINCKalb Michael Wayne
EVP & Chief Financial Officer
280,052$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:37 pm
N/A
2032-01-10
CinCor Pharma Inc.CINCLee June
Director
47,954$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:36 pm
N/A
2031-03-13
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
138,372$00
(Direct)
View
2023-02-24
Equity Swap
2023-02-24
6:36 pm
N/A
N/A
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
141,649$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:35 pm
N/A
2031-06-17
CinCor Pharma Inc.CINCTHERO JOHN F
Director
95,147$00
(Direct)
View
2023-02-24
Disposition
2023-02-24
6:34 pm
N/A
2031-06-17
CinCor Pharma Inc.CINCde Garidel Marc
Chief Executive Officer
1,528,384$00
(Direct)
View
2023-02-24
Equity Swap
2023-02-24
6:34 pm
N/A
N/A
CinCor Pharma Inc.CINCde Garidel Marc
Chief Executive Officer
12,500$00
(Direct)
View
2023-01-26
Option Award
2023-01-30
8:08 pm
N/A
N/A
CinCor Pharma Inc.CINCde Garidel Marc
Chief Executive Officer
200,000$0212,500
(Direct)
View
2023-01-26
Option Award
2023-01-30
8:07 pm
N/A
N/A
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
15,000$0156,649
(Direct)
View
2023-01-26
Option Award
2023-01-30
8:04 pm
N/A
N/A
CinCor Pharma Inc.CINCKalb Michael Wayne
EVP & Chief Financial Officer
177,000$0202,437
(Direct)
View
2023-01-26
Option Award
2023-01-30
8:03 pm
N/A
N/A
CinCor Pharma Inc.CINCFreeman Mason
Chief Medical Officer
40,000$042,600
(Direct)
View
2023-01-11
Tax Withholding
2023-01-19
4:34 pm
N/A
N/A
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
3,997$28.75154,885
(Direct)
View
2023-01-11
Exercise
2023-01-19
4:34 pm
N/A
N/A
CinCor Pharma Inc.CINCPearce Catherine
Chief Operating Officer
13,235$0154,885
(Direct)
View
2023-01-06
Option Award
2023-01-10
4:18 pm
2023-01-06
2033-01-05
CinCor Pharma Inc.CINCAllison David D.
Director
1,499$8.341,499
(Direct)
View
2022-11-04
Option Award
2022-11-08
5:08 pm
N/A
2032-11-03
CinCor Pharma Inc.CINCKalb Michael Wayne
EVP & Chief Financial Officer
103,052$0103,052
(Direct)
View
2022-10-07
Option Award
2022-10-12
4:28 pm
2022-10-07
2032-10-06
CinCor Pharma Inc.CINCAllison David D.
Director
524$23.85524
(Direct)
View
2022-08-05
Exercise
2022-08-08
12:57 pm
N/A
N/A
CinCor Pharma Inc.CINCHEALY JAMES
Director
10% Owner
29,411$13.65,603,360
(Direct)
View
2022-08-05
Exercise
2022-08-08
12:57 pm
N/A
2031-12-09
CinCor Pharma Inc.CINCHEALY JAMES
Director
10% Owner
29,411$05,603,360
(Direct)
View
2022-07-08
Option Award
2022-07-20
4:44 pm
2022-07-08
2032-07-07
CinCor Pharma Inc.CINCAllison David D.
Director
881$14.19881
(Direct)
View
2022-04-08
Option Award(A)
2022-07-20
4:39 pm
2022-04-08
2032-04-07
CinCor Pharma Inc.CINCAllison David D.
Director
1,038$12.041,038
(Direct)
View
2022-04-08
Option Award
2022-05-11
7:34 pm
N/A
2032-04-07
CinCor Pharma Inc.CINCAllison David D.
Director
1,038$01,038
(Direct)
View
2022-01-11
Conversion
2022-01-13
9:32 pm
N/A
N/A
CinCor Pharma Inc.CINCGENERAL ATLANTIC GENPAR (BERMUDA) L.P.
GAP (Bermuda) L.P.
GAP Coinvestments CDA L.P.
General Atlantic (CIN) L.P.
General Atlantic (SPV) GP LLC
10% Owner
10,676,470$04,126,470
(Indirect)
View
2022-01-11
Conversion
2022-01-13
9:32 pm
N/A
N/A
CinCor Pharma Inc.CINCGENERAL ATLANTIC L.P.
GENERAL ATLANTIC GENPAR L.P.
General Atlantic Partners 100 L.P.
GAP COINVESTMENTS III LLC
GAP COINVESTMENTS IV LLC
GAP Coinvestments V LLC
General Atlantic Partners (Bermuda) EU L.P.
General Atlantic Partners (Lux) SCSp
General Atlantic (Lux) S.a r.l.
General Atlantic GenPar (Lux) SCSp
10% Owner
10,676,470$04,126,470
(Indirect)
View
2022-01-11
Conversion
2022-01-13
4:45 pm
N/A
N/A
CinCor Pharma Inc.CINC5AM Partners VI LLC
5AM Ventures VI L.P.
5AM Opportunities I (GP) LLC
5AM Opportunities I L.P.
Schwab Andrew J.
PARMAR KUSH
10% Owner
17,017,645$0496,323
(Indirect)
View
2022-01-11
Conversion
2022-01-13
4:40 pm
N/A
N/A
CinCor Pharma Inc.CINCCinRx Pharma LLC
10% Owner
5,379,135$03,630,103
(Direct)
View
2022-01-11
Conversion
2022-01-13
4:38 pm
N/A
N/A
CinCor Pharma Inc.CINCSofinnova Venture Partners X L.P.
Sofinnova Management X L.L.C.
Katabi Maha
10% Owner
23,095,377$05,573,949
(Indirect)
View
2022-01-11
Conversion
2022-01-13
4:36 pm
N/A
N/A
CinCor Pharma Inc.CINCSofinnova Partners SAS
Sofinnova Capital IX
10% Owner
17,017,645$04,087,646
(Indirect)
View
2022-01-11
Conversion
2022-01-13
4:33 pm
N/A
N/A
CinCor Pharma Inc.CINCHEALY JAMES
Director
10% Owner
23,095,377$05,573,949
(Indirect)
View
(A) Indicate amendment filing.
Goto 0, 1, Next